Form 8-K - Current report:
SEC Accession No. 0001104659-06-070431
Filing Date
2006-11-02
Accepted
2006-11-01 21:46:08
Documents
4
Period of Report
2006-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-22923_18k.htm 8-K 41090
2 EX-10 a06-22923_1ex10d1.htm EX-10.1 23943
3 EX-10 a06-22923_1ex10d2.htm EX-10.2 78135
4 EX-10 a06-22923_1ex10d3.htm EX-10.3 39966
  Complete submission text file 0001104659-06-070431.txt   184861
Mailing Address 2001 ALICEANNA STREET BALTIMORE MD 21231-3043
Business Address 2001 ALICEANNA STREET BALTIMORE MD 21231-3043 410-522-5005
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 061180548
SIC: 2836 Biological Products, (No Diagnostic Substances)